Lactobacillus reuteri maintains a functional mucosal barrier during DSS treatment despite mucus layer dysfunction.
Treatment with the probiotic bacterium Lactobacillus reuteri has been shown to prevent dextran sodium sulfate (DSS)-induced colitis in rats. This is partly due to reduced P-selectin-dependent leukocyte- and platelet-endothelial cell interactions, however, the mechanism behind this protective effect...
Main Authors: | Johan Dicksved, Olof Schreiber, Ben Willing, Joel Petersson, Sara Rang, Mia Phillipson, Lena Holm, Stefan Roos |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2012-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3459901?pdf=render |
Similar Items
-
iNOS-dependent increase in colonic mucus thickness in DSS-colitic rats.
by: Olof Schreiber, et al.
Published: (2013-01-01) -
Structural and functional characterisation of mucus adhesion proteins of Lactobacillus reuteri
by: Etzold, Sabrina
Published: (2013) -
In Vivo and In Vitro Detection of Luminescent and Fluorescent Lactobacillus reuteri and Application of Red Fluorescent mCherry for Assessing Plasmid Persistence.
by: Shokoufeh Karimi, et al.
Published: (2016-01-01) -
Investigating the molecular mechanisms of the interactions between Lactobacillus reuteri strains and intestinal mucus
by: Jeffers, Faye
Published: (2012) -
Lactobacillus reuteri Promotes Intestinal Development and Regulates Mucosal Immune Function in Newborn Piglets
by: Minjuan Wang, et al.
Published: (2020-02-01)